Skip to main content

Find Clinical Trials

Home
Conditions
Overactive Bladder Syndrome

Clinical trial condition

Overactive Bladder Syndrome

Explore clinical trials studying Overactive Bladder Syndrome. Study availability and eligibility vary by location and protocol.

68 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Overactive Bladder Syndrome trial results

Completed

Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

NCT01042119

Conditions: Overactive Bladder Syndrome
Locations: University Hospital of Zurich, Clinic for Gynaecology Zurich, Switzerland

View Trial Details

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

NCT00220376

Conditions: Overactive Bladder Syndrome
Locations: Schwarz RTP, North Carolina, United States

View Trial Details

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

NCT00220402

Conditions: Overactive Bladder Syndrome
Locations: Schwarz Monheim, Germany

View Trial Details

Completed

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

NCT00220363

Conditions: Overactive Bladder Syndrome
Locations: Schwarz Monheim, Germany

View Trial Details

Completed

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

NCT00171145

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Completed

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

NCT00170755

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Novartis East Hanover, New Jersey, United States

View Trial Details

Terminated

Yoga for Treatment of Overactive Bladder in Pediatric Patients

NCT05895045

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Duke University Hospital Durham, North Carolina, United States

View Trial Details

Withdrawn

INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder

NCT05309993

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +14 more
Locations: University of New Mexico Albuquerque, New Mexico, United States

View Trial Details